メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Metabolism-based cardiomyocytes production for regenerative therapy

研究成果: ジャーナルへの寄稿 › 総説 › 査読

6   !!Link opens in a new tab 被引用数 (Scopus)

抄録

Human pluripotent stem cells (hPSCs) are currently used in clinical applications such as cardiac regenerative therapy, studying disease models, and drug screening for heart failure. Transplantation of hPSC-derived cardiomyocytes (hPSC-CMs) can be used as an alternative therapy for heart transplantation. In contrast to differentiated somatic cells, hPSCs possess unique metabolic programs to maintain pluripotency, and understanding their metabolic features can contribute to the development of technologies that can be useful for their clinical applications. The production of hPSC-CMs requires stepwise specification during embryonic development and metabolic regulation is crucial for proper embryonic development. These metabolic features have been applied to hPSC-CM production methods, such as mesoderm induction, specifications for cardiac progenitors, and their maturation. This review describes the metabolic programs in hPSCs and the metabolic regulation in hPSC-CM production for cardiac regenerative therapy.

本文言語英語
ページ(範囲)11-20
ページ数10
ジャーナルJournal of Molecular and Cellular Cardiology
巻176
DOI
出版ステータス出版済み - 03-2023
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 分子生物学
  • 循環器および心血管医学

フィンガープリント

「Metabolism-based cardiomyocytes production for regenerative therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル